Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Renata Santos

44 indexed publications match this author name.

ORCID: 0000-0003-2388-4745
OpenAlex: https://openalex.org/A5058075680

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Depression 23 Review Article 21 Receptor Pharmacology 18 Mechanism of Action 17 Anxiety 15 Clinical Trial 13 Systematic Review 12 Safety 9 Observational Study 9 Addiction 8 Aging 7 Treatment-Resistant Depression 7

Journals

European psychiatry: the journal of the Association of European Psychiatrists 4 Scientific reports 3 Therapeutic advances in psychopharmacology 3 Journal of psychopharmacology (Oxford, England) 2 European Psychiatry 2 Frontiers in psychiatry 2 ACS chemical neuroscience 2 Neuroscience and biobehavioral reviews 2

Publication history

Psychedelics and autism spectrum disorder: Mechanistic insights, translational evidence and ethical challenges.Journal of psychiatric research · 2026-10-01 Craving Reduction and Smoking Outcomes in Psilocybin-Assisted and Standard Cessation Care.Revista brasileira de psiquiatria (Sao Paulo, Brazil: 1999) · 2026-09-09 Classic psychedelics and personality: An updated systematic review.Journal of psychopharmacology (Oxford, England) · 2026-08-01 Daily self-assessment within a regimen of microdosing indicates enhanced psychological functioning on microdosing days relative to non-microdosing days.Psychopharmacology · 2026-07-01 Psychoactive mushroom edibles: trends and toxicities reported to the United States National Poison Data System®, 2023-2024.Clinical toxicology (Philadelphia, Pa.) · 2026-03-01 COMPARATIVE EFFICACY AND ACCEPTABILITY OF PSILOCYBIN-KETAMINE AND TYPICAL ANTIDEPRESSANTS FOR MAJOR DEPRESSIVE DISORDER MANAGEMENT: A NETWORK META-ANALYSISThe Study of Phenomena Related to Health · 2026-01-01 Psychedelic-induced behavioral and developmental effects on zebrafish: a systematic review.Progress in neuro-psychopharmacology & biological psychiatry · 2025-10-02 Exploring the Frontiers of Psychedelics: A New Chromatographic Method for Detection and Quantification of Psilocybin and Psilocin in Psilocybe cubensis MushroomsACS Omega · 2025-07-22 Exploring the biocatalysis of psilocybin and other tryptamines: Enzymatic pathways, synthetic strategies, and industrial implications.Biotechnology progress · 2025-01-01 Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelicsFrontiers in Psychiatry · 2024-11-06 UNRAVELLING THE ROLE OF5-HT2AR ACTIVATION IN THE LONG-LASTING BEHAVIORAL EFFECTS OF PSILOCYBINIBRO Neuroscience Reports · 2023-10-01 Author Correction: Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls.Scientific reports · 2022-07-28 Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controlsVIUspace · 2022-06-30 Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls.Scientific reports · 2022-06-30 Classic and non-classic psychedelics for substance use disorder: A review of their historic, past and current researchAddiction Neuroscience · 2022-06-22 Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges.Expert opinion on drug safety · 2022-06-01 Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers.Scientific reports · 2021-11-18 Use of alternative therapy with Psilocybin in oncologic patients with depression and/or anxiety disorders - integrative reviewResearch Society and Development · 2021-08-19 Therapeutic interventions for PTSD - current evidence on the the role of psychedelicsEuropean psychiatry: the journal of the Association of European Psychiatrists · 2021-08-13 Psychedelics and psychiatric disorders: A emerging roleEuropean psychiatry: the journal of the Association of European Psychiatrists · 2021-08-13 Effects of psilocybin-assisted therapy on treatment-resistant depressionEuropean psychiatry: the journal of the Association of European Psychiatrists · 2021-08-13 Psilocybin in the treatment of obsessive-compulsive disorder: What do we know so far?European psychiatry: the journal of the Association of European Psychiatrists · 2021-08-13 Psilocybin in the treatment of obsessive-compulsive disorder: What do we know so far?European Psychiatry · 2021-04-01 Effects of psilocybin-assisted therapy on treatment-resistant depressionEuropean Psychiatry · 2021-04-01 Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action.Journal of psychopharmacology (Oxford, England) · 2021-04-01 Psychedelic Medicines in Major Depression: Progress and Future Challenges.Advances in experimental medicine and biology · 2021-01-01 What is the clinical evidence on psilocybin for the treatment of psychiatric disorders? A systematic review.Porto biomedical journal · 2021-01-01 The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges.Risk management and healthcare policy · 2021-01-01 Effects of Ayahuasca on the Recognition of Facial Expressions of Emotions in Naive Healthy Volunteers: A Pilot, Proof-of-Concept, Randomized Controlled Trial.Journal of clinical psychopharmacology · 2021-01-01 Cross-Sectional Associations Between Lifetime Use of Psychedelic Drugs and Psychometric Measures During the COVID-19 Confinement: A Transcultural Study.Frontiers in psychiatry · 2021-01-01 Effects of Ayahuasca on Personality: Results of Two Randomized, Placebo-Controlled Trials in Healthy Volunteers.Frontiers in psychiatry · 2021-01-01 Polypharmacology or "Pharmacological Promiscuity" In Psychedelic Research: What Are We Missing?ACS chemical neuroscience · 2020-10-21 Hallucinogens/psychedelics resurrected as new tools in psychiatric therapyBrazilian Journal of Psychiatry · 2020-05-31 Therapeutic use of serotoninergic hallucinogens: A review of the evidence and of the biological and psychological mechanisms.Neuroscience and biobehavioral reviews · 2020-01-01 Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer.BMC psychiatry · 2019-10-28 Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature.Therapeutic advances in psychopharmacology · 2019-01-01 Psychedelics and Personality.ACS chemical neuroscience · 2018-10-17 Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews.Expert review of clinical pharmacology · 2018-09-01 Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies.Therapeutic advances in psychopharmacology · 2017-04-01 Classical hallucinogens and neuroimaging: A systematic review of human studies: Hallucinogens and neuroimaging.Neuroscience and biobehavioral reviews · 2016-12-01 Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years.Therapeutic advances in psychopharmacology · 2016-06-01 The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network.PloS one · 2015-01-01 Psychedelics, Glutamate, and Neuroimaging StudiesAnesthesiology · 2014-05-21 Potential Therapeutic Effects of Psilocybin/Psilocin are Minimized While Possible Adverse Reactions are OverratedTherapeutic Drug Monitoring · 2014-02-01

Author directory